NOVEMBER 15, 2021
Kuttner on TAP
Bipartisanship Lives—Thanks to China
Schumer moves to add a major technology bill to the must-pass defense authorization.
Bipartisanship may be dead when it comes to building back better, but it may be alive and well when it comes to resisting China and rebuilding U.S. supply chains and domestic industry. Last June, the Senate passed the bipartisan United States Innovation and Competition Act (USICA) by a filibuster-proof vote of 68-32.

Majority Leader Chuck Schumer cobbled together the bill working with the Democratic chairs of key Senate committees and their Republican counterparts. Among other provisions, the $200 billon legislation includes $52.7 billion to restore U.S. domestic leadership in semiconductors, addresses the supply chain crisis in other respects, and creates a Directorate of Technology and Innovation at the National Science Foundation funded at $81 billion.

USICA also cracks down on a variety of predatory trade and intellectual-property practices on the part of China, and adds sanctions for human rights abuses. This is the first major legislation to take seriously the threat of China’s authoritarian state capitalism with a proportional response.

The bill has been bottled up in the House. But last night, in a "Dear Colleague" letter that was released to the press, discussing legislative plans for the coming months, Schumer announced a shrewd tactical ploy. He will seek to tack USICA onto the must-pass annual National Defense Authorization Act. "I have had a number of conversations with Senators on both sides of the aisle and there seems to be fairly broad support for doing so," he wrote.

Good for Schumer. Reviving U.S. manufacturing and supply chains is surely a national-security issue. If we can’t get all of Build Back Better, we can at least get some of the crucial industrial-policy provisions. The Republicans are obstructionist on almost everything—but leave it to China’s President Xi Jinping to bring the parties together.
In a familiar tactic, the Chamber manufactures an alternative to a broadly bipartisan effort to end forced arbitration for workplace sexual misconduct cases. BY DAVID DAYEN
The Billionaire Behind the Fight for Lower Drug Prices
A former Enron executive has poured tens of millions into national drug pricing reform. Why hasn’t it worked? BY ROSE ADAMS
Killer Robots and Conflicts of Interest
A consultant and her clients share the stage of Washington Post Live. BY JONATHAN GUYER
The Strikes Beyond the Barricades at COP26
A wave of strikes in Glasgow exposes the need to center workers in climate policy. BY ELLA FANGER
Young Climate Activists Fund Global South Projects
The West hasn’t lived up to climate financing pledges for developing countries, so young people raise funds in their own countries to solve local problems. BY ESTHER ERIKSSON VON ALLMEN
 
Click to Share this Newsletter
 
 
 
 
DID YOU KNOW?
Per the Cares Act extension for 2021 charitable donations, you can deduct up to $600 from your taxes even if you don't itemize.
The American Prospect, Inc.
1225 I Street NW, Suite 600
Washington, DC xxxxxx
United States
Copyright (C) 2021 The American Prospect. All rights reserved.

To opt out of American Prospect membership messaging, click here.
To manage your newsletter preferences, click here.
To unsubscribe from all American Prospect emails, including newsletters, click here.